Cargando…

P401 Identification and characterization of cryptic species of Aspergillus isolated from clinical samples

POSTER SESSION 3, SEPTEMBER 23, 2022, 12:30 PM - 1:30 PM:   BACKGROUND AND OBJECTIVE: Molds are emerging as a major cause of life-threatening infections in immunocompromised patients. There is an increasing recognition of the cryptic Aspergillus species, which are organisms that are morphologically...

Descripción completa

Detalles Bibliográficos
Autores principales: Janani R., Sruti, Singh, Gagandeep, Xess, Immaculata, Das, Bimal Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509977/
http://dx.doi.org/10.1093/mmy/myac072.P401
_version_ 1784797348857118720
author Janani R., Sruti
Singh, Gagandeep
Xess, Immaculata
Das, Bimal Kumar
author_facet Janani R., Sruti
Singh, Gagandeep
Xess, Immaculata
Das, Bimal Kumar
author_sort Janani R., Sruti
collection PubMed
description POSTER SESSION 3, SEPTEMBER 23, 2022, 12:30 PM - 1:30 PM:   BACKGROUND AND OBJECTIVE: Molds are emerging as a major cause of life-threatening infections in immunocompromised patients. There is an increasing recognition of the cryptic Aspergillus species, which are organisms that are morphologically indistinguishable yet can be differentiated by molecular methods. These organisms have been known to show a higher minimal inhibitory concentration for the majority of the antifungal agents in vitro. Therefore, correct identification of these cryptic species is very important to administer a proper antifungal agent. In this study, we wish to identify and characterize the cryptic species of Aspergillus from all clinical samples. METHODS: Patient routine samples like broncho alveolar lavage, endo-tracheal aspirate, sputum, pus, tissue, and CSF from various wards, OPDs, and ICUs of All India Institute of Medical Sciences, New Delhi which were processed in the Mycology laboratory, department of Microbiology showing growth of Aspergillus species were included in this study. Identification of the isolates was done using phenotypic methods and by Matrix Assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF). For the analysis of cryptic species, the isolates underwent PCR and then sequencing of the ß-tubulin gene was done. Antifungal susceptibility testing was done using micro broth dilution as per the CLSI method. RESULTS: Of the 92 isolates, using morphological methods, 53 were identified as A. fumigatus, 33 were identified as A. flavus, 3 as A. nidulans, 2 as A. terreus, and 1 as A. niger MALDI-TOF (Vitek MS database) misidentified 2 isolates of A. nidulans and 1 isolate of A, stellatus as A. fumigatus and 1 isolate of A. tubingensis as A. niger. The ß-tubulin sequence analysis for the identification of cryptic species revealed that 2 isolates (2.08%) were cryptic, one was A. stellatus morphologically identified as A. nidulans and another one was A. tubingensis morphologically identified as A. niger. CONCLUSION: Currently the available data on cryptic Aspergillus species is very limited. Because of its varied susceptibility pattern, it is important to identify the Aspergillus isolates to its species level. There is also a need for expansion of the number of strains for each species in MALDI-TOF MS databases for convenient, faster, and correct identification.
format Online
Article
Text
id pubmed-9509977
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-95099772022-09-26 P401 Identification and characterization of cryptic species of Aspergillus isolated from clinical samples Janani R., Sruti Singh, Gagandeep Xess, Immaculata Das, Bimal Kumar Med Mycol Oral Presentations POSTER SESSION 3, SEPTEMBER 23, 2022, 12:30 PM - 1:30 PM:   BACKGROUND AND OBJECTIVE: Molds are emerging as a major cause of life-threatening infections in immunocompromised patients. There is an increasing recognition of the cryptic Aspergillus species, which are organisms that are morphologically indistinguishable yet can be differentiated by molecular methods. These organisms have been known to show a higher minimal inhibitory concentration for the majority of the antifungal agents in vitro. Therefore, correct identification of these cryptic species is very important to administer a proper antifungal agent. In this study, we wish to identify and characterize the cryptic species of Aspergillus from all clinical samples. METHODS: Patient routine samples like broncho alveolar lavage, endo-tracheal aspirate, sputum, pus, tissue, and CSF from various wards, OPDs, and ICUs of All India Institute of Medical Sciences, New Delhi which were processed in the Mycology laboratory, department of Microbiology showing growth of Aspergillus species were included in this study. Identification of the isolates was done using phenotypic methods and by Matrix Assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF). For the analysis of cryptic species, the isolates underwent PCR and then sequencing of the ß-tubulin gene was done. Antifungal susceptibility testing was done using micro broth dilution as per the CLSI method. RESULTS: Of the 92 isolates, using morphological methods, 53 were identified as A. fumigatus, 33 were identified as A. flavus, 3 as A. nidulans, 2 as A. terreus, and 1 as A. niger MALDI-TOF (Vitek MS database) misidentified 2 isolates of A. nidulans and 1 isolate of A, stellatus as A. fumigatus and 1 isolate of A. tubingensis as A. niger. The ß-tubulin sequence analysis for the identification of cryptic species revealed that 2 isolates (2.08%) were cryptic, one was A. stellatus morphologically identified as A. nidulans and another one was A. tubingensis morphologically identified as A. niger. CONCLUSION: Currently the available data on cryptic Aspergillus species is very limited. Because of its varied susceptibility pattern, it is important to identify the Aspergillus isolates to its species level. There is also a need for expansion of the number of strains for each species in MALDI-TOF MS databases for convenient, faster, and correct identification. Oxford University Press 2022-09-20 /pmc/articles/PMC9509977/ http://dx.doi.org/10.1093/mmy/myac072.P401 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Oral Presentations
Janani R., Sruti
Singh, Gagandeep
Xess, Immaculata
Das, Bimal Kumar
P401 Identification and characterization of cryptic species of Aspergillus isolated from clinical samples
title P401 Identification and characterization of cryptic species of Aspergillus isolated from clinical samples
title_full P401 Identification and characterization of cryptic species of Aspergillus isolated from clinical samples
title_fullStr P401 Identification and characterization of cryptic species of Aspergillus isolated from clinical samples
title_full_unstemmed P401 Identification and characterization of cryptic species of Aspergillus isolated from clinical samples
title_short P401 Identification and characterization of cryptic species of Aspergillus isolated from clinical samples
title_sort p401 identification and characterization of cryptic species of aspergillus isolated from clinical samples
topic Oral Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509977/
http://dx.doi.org/10.1093/mmy/myac072.P401
work_keys_str_mv AT jananirsruti p401identificationandcharacterizationofcrypticspeciesofaspergillusisolatedfromclinicalsamples
AT singhgagandeep p401identificationandcharacterizationofcrypticspeciesofaspergillusisolatedfromclinicalsamples
AT xessimmaculata p401identificationandcharacterizationofcrypticspeciesofaspergillusisolatedfromclinicalsamples
AT dasbimalkumar p401identificationandcharacterizationofcrypticspeciesofaspergillusisolatedfromclinicalsamples